Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Asure Software's 2026 HR Benchmark Report reveals that small business owners are increasingly uncertain about their compliance with employment laws, especially those experiencing downturns. The company emphasizes that growing businesses are more proactive in HR best practices and promotes its AsureWorks managed service to help alleviate compliance …
red violet, Inc.'s subsidiary FOREWARN has announced a collaboration with Pacific West Association of REALTORS® to provide FOREWARN's real-time identity verification services to over 10,000 members across California. The service, accessible online and via mobile app, enables real estate agents to verify identities, check criminal histories, and val…
Merlin, Inc. announced a strategic pivot to pursue civil certification and deployment of its autonomous flight technology for large aircraft instead of small ones. Building on its defense sector success with programs like the C-130J autonomy project, Merlin aims to address the large commercial aircraft market, where pilot shortages and operational …
Academy Sports and Outdoors, Inc. reported a 3% increase in net sales for the second quarter of fiscal 2026, with diluted GAAP EPS rising 17.3% to $2.17 and adjusted EPS up 19.1% to $2.31. The company opened three new stores and expanded eCommerce sales by 12.8%. Academy reaffirmed its fiscal 2026 sales guidance while increasing EPS expectations, h…
Aktis Oncology, a clinical-stage cancer therapy company specializing in targeted radiopharmaceuticals, announced CEO Matthew Roden's participation in two major investor conferences in September 2026 to present their innovative radioconjugate platform and clinical programs. The company highlighted its proprietary miniprotein platform, clinical trial…
NANO Nuclear Energy Inc. (NASDAQ: NNE) announced the appointment of Marilyn Diaz, a seasoned nuclear regulatory executive with 17 years at the U.S. Nuclear Regulatory Commission, as Director of Fuel Facilities Operations. Diaz's expertise in nuclear fuel facility regulation and advanced reactor policy is expected to strengthen NANO Nuclear's vertic…
Bakkt, Inc. announced the expansion of its global commercial team to accelerate the scaling of its digital asset infrastructure and payments platform. The company raised its 2026 Total Transacting Volume target from $2.5 billion to $3 billion, reflecting increased customer demand and a strong pipeline. Bakkt is also developing product suites target…
MBX Biosciences, a clinical-stage biopharmaceutical company specializing in precision peptide therapies for endocrine and metabolic disorders, announced its CEO and CMO will present at the Morgan Stanley 24th Annual Global Healthcare Conference and the Stifel 2026 Virtual Cardiometabolic Forum. The company provides webcast access to these events th…
Humacyte announced FDA authorization to extend the shelf life of its bioengineered vascular product, Symvess, from 18 months to 36 months, supported by stability data. This extension facilitates better inventory management, reduces waste, and enhances hospital adoption of Symvess. Symvess is FDA-approved for urgent extremity vascular trauma and is …
The Professional Women's Hockey League (PWHL) announces a landmark national broadcast agreement with Scripps Sports for the 2026-27 season. The deal provides U.S. fans with exclusive access to PWHL games, including a weekly 'Game of the Week' on ION network and additional games on free streaming services, marking the league's first full-season nati…
Castellum, Inc., a cybersecurity and electronic warfare company focused on U.S. national security, announced its leadership will present at the upcoming H.C. Wainwright Global Investment Conference. The presentation aims to highlight the company's expertise and strategic initiatives, including acquisitions to enhance its capabilities in cybersecuri…
electroCore, a Nasdaq-listed bioelectronic medicine company, has named Joshua Lev and Mike Fox as Co-Chief Executive Officers following a strategic leadership succession process. The co-CEO structure aims to combine Lev’s financial and strategic expertise with Fox’s commercial and operational strengths to accelerate growth, build new markets, and a…
Mint Incorporation Limited announced that its joint venture Rice Robotics AGI Holding Limited has signed a non-binding Memorandum of Understanding with Edvance Innovation Limited to establish a strategic distribution partnership focused on deploying educational robotics products and curricula across the Middle East and North Africa (MENA) region. T…
INmune Bio Inc., a NASDAQ-listed late-stage biotech company focused on inflammation and immunology, announced its participation at the H.C. Wainwright 28th Annual Global Investment Conference. The event includes a presentation by CEO David Moss detailing progress in their clinical-stage platforms CORDStrom and XPro1595, with upcoming regulatory mil…
AEON Biopharma announced positive outcomes from a pilot forced degradation study comparing its biosimilar candidate ABP-450 to the reference product BOTOX®. The study demonstrated comparable potency loss patterns under thermal and oxidative stress, providing additional analytical evidence supporting structural and functional similarity. These findi…
EVgo Inc., a leading public fast charging provider for electric vehicles, is expanding its partnership with Regency Centers Corporation to install over 400 new fast-charging stalls at Regency's shopping centers across multiple U.S. states. This expansion will increase Regency's EV charging footprint by more than 20%, providing convenient, high-spee…
ProQR Therapeutics has dosed the first healthy volunteer in its Phase 1 clinical trial for AX-0811, a next-generation RNA editing oligonucleotide targeting NTCP to treat cholestatic liver diseases such as biliary atresia. The trial will assess safety, tolerability, pharmacokinetics, and pharmacodynamics, with initial data expected in early 2027. Pr…
Mount Logan Capital Inc., a US-based alternative asset management and insurance solutions firm, announced its participation in the Lake Street Capital Markets' 10th Annual Best Ideas Growth (BIG10) Conference. The company will host in-person one-on-one investor meetings to discuss its integrated investment and insurance strategies designed to produ…
J.P. Morgan has cautioned on the European Medtech and Services sector as it moves into the second half of 2026, arguing that the recent rebound has not been matched by a proportional improvement in earnings revisions. While the broker highlighted pockets of strength - notably in hearing aids and several companies that beat and raised guidance - it …
TKO's cash flow and demonstrated shareholder returns (dividend hike and buybacks) set a base; a near-term earnings beat is plausible if the company sells more around marquee UFC and WWE events. Technicals, insider buying and high short activity add a tactical edge. Trade plan: enter $190.00, target $220.00, stop $175.00, horizon mid term (45 tradin…
The European Commission on Wednesday proposed a single EU-wide public procurement regulation and a digital procurement platform designed to simplify tendering, curb excessive paperwork and give authorities more room to factor in strategic concerns such as supply-chain resilience and foreign influence. The plan would replace three existing directive…
Barclays increased its year-end 2026 S&P 500 price target to 7,950 from 7,800 and kept the 2027 target at 8,800 after a strong second-quarter earnings cycle driven by technology companies. The bank raised fiscal 2026 and 2027 EPS estimates, highlighted broad earnings beats, and kept cautious valuation multiples despite improved fundamentals. Sector…
UBS HOLT analyst Michel Lerner cautions that U.S. equities may be the most vulnerable among developed markets if rising government bond yields begin to weigh on stocks. Lerner points to a mix of geopolitical and fiscal pressures that have pushed yields to levels not seen since before the global financial crisis, while equity valuations - particular…
Dow Inc. is considering options to divest its 35% stake in the $20 billion Sadara Chemical Co. joint venture with Saudi Aramco, according to Bloomberg News. The deliberations form part of Dow's portfolio reshaping in the face of an extended downturn in the chemicals sector. No final decision has been made, and discussions remain confidential.
Dyne Therapeutics (DYN) has pulled back after a Novartis trial failure that hit the DM1 class. The pullback creates a tactical entry: Dyne's differentiated delivery platform, multiple clinical programs and manageable balance-sheet profile make the risk/reward favorable from a swing and longer-term perspective. We lay out an actionable trade with pr…
